1. Home
  2. Southern Africa
  3. South Africa

Lobby group urges cheaper AIDS drugs

A South African AIDS lobby group has lost 100 of its activists to AIDS-related illnesses in a period of just over a four months.

The Treatment Action Campaign (TAC) said most of the members who died between March and July 2003 were women younger than 24, and only one was using anti-HIV/AIDS drugs.

Zackie Achmat, chairman of the TAC, called on the government to make the drugs more easily accessible to people living with HIV/AIDS by reducing the price to under R200.00 (US $28.53) per month. The drugs currently sell at R300.00 ($42.79) per monthly dose.

He said the government could achieve this by issuing licences for the local manufacture of generic versions of the drugs.

Achmat was quoted by the South African Press Association (SAPA) as saying: "I am confident the government will act urgently on this. Six hundred people die in our country every day, which is a tragedy. But, even worse is that, there are 1,500 new infections every day."


This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join